Skip to main content

From drones to smart pills, 2018 saw significant tech advances in medicine

Ascom / MCTIC

Robots, A.I. algorithms, and drone deliveries are increasingly found in just about every industry and profession. Why not the medical world, too? To that end, 2018 saw an impressive convergence of cutting-edge technology and groundbreaking medical research.

Recommended Videos

It is, of course, crucial that any new technology is properly investigated before it finds its way to patients, but — when the right steps are taken — these tools can be a game changer when it comes to health and wellness. Here are some of the biggest medical tech stories that caught our eye this year.

Medical drone deliveries

We’re still not at the point where most of us can get a book or DVD (if people still buy those!) delivered by drone, but drone-based medical deliveries nonetheless made big strides in 2018.

A pioneering medical trial by the University of Maryland demonstrated that drones could be used for safely transporting a potentially lifesaving transplant organ. They did this by putting a kidney in a cooler and flying it underneath a DJI M600 Pro drone to see if it suffered any damage. It didn’t — and the organ actually experienced fewer vibrations than it would when being transported in a fixed-wing plane.

Zipline

Meanwhile, Zipline unveiled a new, faster drone for delivering vital medical services such as blood supplies. For the past two years, Zipline has delivered blood for vital transfusions to remote clinics in Rwanda. The company’s new drone — which it claims is the fastest commercial delivery drone around — will make this mission more efficient. It’s got its eye on offering similar services in the U.S., too.

Wonders (and blunders) of gene editing

2018 was a significant year for advances in CRISPR gene editing. Operating in animal (predominantly mice) models, researchers demonstrated how severe obesity, autism, Duchenne muscular dystrophy, dementia, cocaine addiction, and other conditions can potentially be treated with careful use of gene therapy.

While these advances were generally met with favorable responses from the scientific community, a reported experiment coming out of China most certainly was not.

In the most infamous “medical advance” of 2018, researchers in China reportedly delivered the world’s first twins who had been genetically altered as embryos to remove a gene associated with potentially fatal diseases such as HIV, smallpox, and cholera.

The news received immediate backlash and intense criticism from around the world. Provided that the report is accurate (details have been far from forthcoming), this nonetheless represents a major landmark. Just not a landmark many hoped would be reached without far more research.

Bioengineered tissues and organs

There’s a massive shortage of available transplant organs. One potential solution would be to be able to grow new ones in the lab. While we’re not yet at the point at which this is entirely possible, 2018 moved the research in the right direction. The field of 3D bioprinting continued to make strides through the demonstration of 3D-printed human cardiac tissue.

3D-printed prototype for bionic eye

One of the other significant advances from our perspective was the creation of bioengineered lungs at the University of Texas Medical Branch at Galveston. These were then successfully transplanted into pigs, allowing them to breathe normally with no medical complications.

Transferring that research to clinical trials for humans is likely to take another five to eight years of preclinical testing. It’s an important advance, however.

Smart pills

Our phones have been smart for a decade now, our watches for a bit less than that, and our homes are getting smarter all the time. Why not smart pills as well?

That’s what researchers from RMIT University in Melbourne, Australia, demonstrated this year with the creation of a functioning electronic capsule which, once swallowed, measures gas biomarkers as it travels through the gut. As it does this, it gathers information relating to food, gut environment, and more — before transmitting it out of the body to a smartphone or other device. It could be useful for diagnosing diseases from irritable bowel syndrome and inflammatory bowel disease to potentially fatal ones such as colon cancer.

While it’s not quite ready for prime time, researchers have completed a successful phase 1 trial on 26 healthy individuals, proving the capsules’ safety and efficacy. Another not dissimilar project — also from researchers in Australia — explores how the smart pill experience could be “gamified” for the benefit of users.

Medical robots

Medical robots are getting better all the time. This year, neurosurgeons and otolaryngologists at the University of Pennsylvania’s Perelman School of Medicine reported performing the world’s first robot-assisted spinal surgery. This complex procedure involved the use of robot arms to remove a tumor from the neck of a 27-year-old patient.

Pediatric HAL®: The World's Most Advanced Pediatric Patient Simulator

For the procedure, neurosurgeons entered the patient’s body through the neck and cut the spine around the tumor. A team of three (human) surgeons then utilized the surgical robot to remove the tumor through the patient’s mouth. The spinal column was then reconstructed, using a hip bone and additional rods for stability.

“There are two components that make this work so exciting,” Dr. Neil Malhotra, one of the surgeons involved in the procedure, told Digital Trends. “One is that it permits us to switch from palliation for certain types of tumors to, in some cases for the first time, seeking cures. For the second point, this approach is less traumatic for the patient, which means a better recovery.”

Algorithm that predict mortality

No, no one in their right mind is suggesting replacing flesh-and-blood doctors with algorithms. However, machine learning tools definitely have their predictive place in modern medicine. With that in mind, the U.S. Food and Drug Administration this year granted its clearance for an algorithm that’s used in hospitals to help predict (and, hopefully, prevent) sudden patient deaths.

The Wave Clinical Platform works by monitoring patients’ vital signs and sending alerts warning about impending heart attacks or respiratory failure up to six hours before a patient suffers such an event. What makes the system so smart is that it not only monitors multiple biometrics for patients, but analyzes these in conjunction with one another. For example, a minor decrease in a patient’s respiratory rate wouldn’t usually be enough to trigger an emergency call. But if it’s accompanied by a spike in blood pressure, this could suggest something far more worrying.

A clinical trial among elderly patients at the University of Pittsburgh Medical Center showed that a group using the technology experienced fewer unexpected deaths than those who did not.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Star Wars legend Ian McDiarmid gets questions about the Emperor’s sex life
Ian McDiarmid as the Emperor in Star Wars: The Rise of Skywalker.

This weekend, the Star Wars: Revenge of the Sith 20th anniversary re-release had a much stronger performance than expected with $25 million and a second-place finish behind Sinners. Revenge of the Sith was the culmination of plans by Chancellor Palpatine (Ian McDiarmid) that led to the fall of the Jedi and his own ascension to emperor. Because McDiarmid's Emperor died in his first appearance -- 1983's Return of the Jedi -- Revenge of the Sith was supposed to be his live-action swan song. However, Palpatine's return in Star Wars: Episode IX -- The Rise of Skywalker left McDiarmid being asked questions about his character's comeback, particularly about his sex life and how he could have a granddaughter.

While speaking with Variety, McDiarmid noted that fans have asked him "slightly embarrassing questions" about Palpatine including "'Does this evil monster ever have sex?'"

Read more
Waymo and Toyota explore personally owned self-driving cars
Front three quarter view of the 2023 Toyota bZ4X.

Waymo and Toyota have announced they’re exploring a strategic collaboration—and one of the most exciting possibilities on the table is bringing fully-automated driving technology to personally owned vehicles.
Alphabet-owned Waymo has made its name with its robotaxi service, the only one currently operating in the U.S. Its vehicles, including Jaguars and Hyundai Ioniq 5s, have logged tens of millions of autonomous miles on the streets of San Francisco, Los Angeles, Phoenix, and Austin.
But shifting to personally owned self-driving cars is a much more complex challenge.
While safety regulations are expected to loosen under the Trump administration, the National Highway Traffic Safety Administration (NHTSA) has so far taken a cautious approach to the deployment of fully autonomous vehicles. General Motors-backed Cruise robotaxi was forced to suspend operations in 2023 following a fatal collision.
While the partnership with Toyota is still in the early stages, Waymo says it will initially study how to merge its autonomous systems with the Japanese automaker’s consumer vehicle platforms.
In a recent call with analysts, Alphabet CEO Sundar Pichai signaled that Waymo is seriously considering expanding beyond ride-hailing fleets and into personal ownership. While nothing is confirmed, the partnership with Toyota adds credibility—and manufacturing muscle—to that vision.
Toyota brings decades of safety innovation to the table, including its widely adopted Toyota Safety Sense technology. Through its software division, Woven by Toyota, the company is also pushing into next-generation vehicle platforms. With Waymo, Toyota is now also looking at how automation can evolve beyond assisted driving and into full autonomy for individual drivers.
This move also turns up the heat on Tesla, which has long promised fully self-driving vehicles for consumers. While Tesla continues to refine its Full Self-Driving (FSD) software, it remains supervised and hasn’t yet delivered on full autonomy. CEO Elon Musk is promising to launch some of its first robotaxis in Austin in June.
When it comes to self-driving cars, Waymo and Tesla are taking very different roads. Tesla aims to deliver affordability and scale with its camera, AI-based software. Waymo, by contrast, uses a more expensive technology relying on pre-mapped roads, sensors, cameras, radar and lidar (a laser-light radar), that regulators have been quicker to trust.

Read more
Uber partners with May Mobility to bring thousands of autonomous vehicles to U.S. streets
uber may mobility av rides partnership

The self-driving race is shifting into high gear, and Uber just added more horsepower. In a new multi-year partnership, Uber and autonomous vehicle (AV) company May Mobility will begin rolling out driverless rides in Arlington, Texas by the end of 2025—with thousands more vehicles planned across the U.S. in the coming years.
Uber has already taken serious steps towards making autonomous ride-hailing a mainstream option. The company already works with Waymo, whose robotaxis are live in multiple cities, and now it’s welcoming May Mobility’s hybrid-electric Toyota Sienna vans to its platform. The vehicles will launch with safety drivers at first but are expected to go fully autonomous as deployments mature.
May Mobility isn’t new to this game. Backed by Toyota, BMW, and other major players, it’s been running AV services in geofenced areas since 2021. Its AI-powered Multi-Policy Decision Making (MPDM) tech allows it to react quickly and safely to unpredictable real-world conditions—something that’s helped it earn trust in city partnerships across the U.S. and Japan.
This expansion into ride-hailing is part of a broader industry trend. Waymo, widely seen as the current AV frontrunner, continues scaling its service in cities like Phoenix and Austin. Tesla, meanwhile, is preparing to launch its first robotaxis in Austin this June, with a small fleet of Model Ys powered by its camera-based Full Self-Driving (FSD) system. While Tesla aims for affordability and scale, Waymo and May are focused on safety-first deployments using sensor-rich systems, including lidar—a tech stack regulators have so far favored.
Beyond ride-hailing, the idea of personally owned self-driving cars is also gaining traction. Waymo and Toyota recently announced they’re exploring how to bring full autonomy to private vehicles, a move that could eventually bring robotaxi tech right into your garage.
With big names like Uber, Tesla, Waymo, and now May Mobility in the mix, the ride-hailing industry is evolving fast—and the road ahead looks increasingly driver-optional.

Read more